To qualify, participants must be 6 years or older. Qualified participants will receive free study medication, examinations and labs. Participants must be available for a 4 week to 10 month commitment, depending on the study.
Some studies have monetary compensation.
All study drugs, office visits and tests required for the study will be provided at no cost to qualified participants. Financial compensation available for qualified participants. The study drug, rhuMAb-E25, is a type of medication called a monoclonal antibody. It inactivates agents in the blood that can cause allergic reactions. The patient would be on treatment for approximately 6 months.